Hormone receptors: In breast cancer, SOX2 and MALAT1 were upregulated in ER/PR-negative and HER2-positive cases, reflecting their association with more aggressive phenotypes [11,37]. This evidence concerns the gene MALAT1 and breast carcinoma.